Videos
Advertisement
Multiple Myeloma Awareness Month is marked each year in March.
Heidi Haynes, MN, CRNP, OCN, of the Oncology Nursing Society Board of Directors, highlights the chapters and resources.
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
Martha Raymond, MA, of the GI Cancers Alliance, shares insights from a yearlong study that gathered patient perspectives.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
The Tandem Transplantation and Cellular Therapy Meetings offer a dedicated nursing track, networking opportunities, and more.
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15.
Martha Raymond, MA, founder of the GI Cancers Alliance, shares insights from her recent presentation on the programming.
Prithviraj Bose, MD, unpacks key highlights in MPN treatment and research at ASH 2024.
Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research.
Lisa Hwa, APRN, CNP, DNP, MS, is a member of the ASH Medical Educators Institute and has presented multiple ASH abstracts.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, shares her hopes for the new year.
Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease.
Amy Pierre, RN, BSN, ANP-BC, reflects on highlights from ASH 2024 and why it's critical for advanced practitioners to attend.
An expert in pediatric GVHD shares his hopes and projections for the future of GVHD treatment and research.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.